obesity-995x60.png
FEATURED ARTICLES
To Pick The Right Medical LLM, First Assess Your Readiness
Learn how to evaluate medical LLMs for clinical trials by weighing readiness, risk, validation, integration, hidden costs, and supplier controls.
-
![GettyImages-1456819866-home-health-monitoring]( "Engaged Patients, Better Data")
Engaged Patients, Better DataAutomatically triggered micropayments tied to completed questionnaires connect patient-reported data collection with payment administration, aiming to support engagement while taking manual payment work off site staff.
-
![GettyImages-869290346 protocol]( "Combining Multiple Challenge Models Within A Single Individual")
Combining Multiple Challenge Models Within A Single IndividualPairing immune challenges in healthy volunteers tests whether pharmacology is consistent across cells, tissue, and systemic responses before patient trials.
-
![Medical safety, drug monitoring, clinical research, pharmacovigilance-GettyImages-2242535196]( "What Most Psychiatric Drug Development Programmes Learn Too Late")
What Most Psychiatric Drug Development Programmes Learn Too LateClinical phase completion doesn’t end uncertainty. Six key questions on brain exposure, pharmacology, therapeutic window, and patient variability can reveal whether the molecule failed, or the mechanism.
SERVICES AND PRODUCTS
Explore the breadth of Altasciences’ expertise in clinical pharmacology studies, supporting regulatory submissions across a diverse range of therapeutic areas.
Managing clinical trial disclosure can be challenging with the ever-evolving regulatory landscape, and varying requirements across different jurisdictions and regulatory bodies. New and updated regulations need to be continuously monitored and assessed for potential impact on an organization, processes and overall strategy.
Ypsomed accelerates clinical progress by reducing barriers across clinical development, enabling earlier study readiness, greater visibility and more informed decisions.
Explore validated pain models and integrated early-phase services designed to characterize dose response, evaluate safety and efficacy, and support informed decisions in analgesic development.
DECODE, the Digital Endpoint Collaboration for Outcomes Development, is Ametris’ pre-competitive collaboration framework designed to help address shared clinical measurement challenges across the life sciences industry. In regulatory contexts where evidence expectations are high, digital measures must be meaningful to patients, scientifically valid, operationally feasible, and aligned with regulatory expectations. By supporting the development and validation of fit-for-purpose, patient-centered digital measures, DECODE helps transform real-world data into validated clinical evidence across clinical research programs.